Ocugen Inc Stock Filter Stocks by Fundamentals
| OCGN Stock | USD 1.32 0.12 8.33% |
Ocugen Inc fundamentals help investors to digest information that contributes to Ocugen's financial success or failures. It also enables traders to predict the movement of Ocugen Stock. The fundamental analysis module provides a way to measure Ocugen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ocugen stock.
Ocugen | Shares Owned by Institutions |
Ocugen Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ocugen from analyzing Ocugen's financial statements. These drivers represent accounts that assess Ocugen's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ocugen's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 7.2M | 205.4M | 887.3M | 279.0M | 251.1M | 221.1M | |
| Enterprise Value | 1.2M | 183.8M | 795.7M | 207.8M | 187.0M | 188.2M |
Ocugen Institutional Holders
Institutional Holdings refers to the ownership stake in Ocugen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ocugen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ocugen's value.| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 296.2 K | Cubist Systematic Strategies, Llc | 2023-12-31 | 265.5 K | Renaissance Technologies Corp | 2023-12-31 | 246.2 K | T. Rowe Price Associates, Inc. | 2023-12-31 | 187.1 K | Jpmorgan Chase & Co | 2023-12-31 | 182.8 K | Charles Schwab Investment Management Inc | 2023-12-31 | 170.3 K | Two Sigma Investments Llc | 2023-12-31 | 157.3 K | Bank Of America Corp | 2023-12-31 | 155.2 K | D. E. Shaw & Co Lp | 2023-09-30 | 139 K | Vanguard Group Inc | 2023-12-31 | 12 M | Blackrock Inc | 2023-12-31 | 3.7 M |
Ocugen Fundamentals
| Return On Equity | -1.01 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (1.43) % | ||||
| Current Valuation | 338.03 M | ||||
| Shares Outstanding | 257.32 M | ||||
| Shares Owned By Insiders | 1.45 % | ||||
| Shares Owned By Institutions | 10.33 % | ||||
| Number Of Shares Shorted | 43.48 M | ||||
| Price To Earning | (1.81) X | ||||
| Price To Book | 7.51 X | ||||
| Price To Sales | 25,069 X | ||||
| Revenue | 6.04 M | ||||
| Gross Profit | (49.76 M) | ||||
| EBITDA | (64.83 M) | ||||
| Net Income | (63.08 M) | ||||
| Cash And Equivalents | 101.6 M | ||||
| Cash Per Share | 0.46 X | ||||
| Total Debt | 6.37 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 7.21 X | ||||
| Book Value Per Share | 0.16 X | ||||
| Cash Flow From Operations | (62.05 M) | ||||
| Short Ratio | 4.05 X | ||||
| Earnings Per Share | (0.26) X | ||||
| Target Price | 5.33 | ||||
| Beta | 3.74 | ||||
| Market Capitalization | 370.55 M | ||||
| Total Asset | 64.55 M | ||||
| Retained Earnings | (286.17 M) | ||||
| Working Capital | 25.88 M | ||||
| Current Asset | 17.53 M | ||||
| Current Liabilities | 4.21 M | ||||
| Net Asset | 64.55 M |
About Ocugen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ocugen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ocugen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ocugen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ocugen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ocugen's short interest history, or implied volatility extrapolated from Ocugen options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Ocugen Piotroski F Score and Ocugen Altman Z Score analysis. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Ocugen Stock analysis
When running Ocugen's price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Ocugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Revenue Per Share 0.025 | Quarterly Revenue Growth 1.426 | Return On Assets (0.47) | Return On Equity (1.01) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.